Location History:
- Margny-les-Compiègne, FR (2006)
- Margny-les-Compiégne, FR (2010)
Company Filing History:
2 out of 869 
2 out of 1,743 
2 out of 5,072 
Years Active: 2006-2010
Title: The Innovative Genius of Anne-Sophie Belzacq
Introduction
Anne-Sophie Belzacq, an accomplished inventor based in Margny-les-Compiégne, France, has made significant contributions to the field of biomedical research. With two patents to her name, she has focused her research on the mechanisms of human immunodeficiency virus (HIV) interactions, particularly how they affect mitochondrial functions.
Latest Patents
Anne-Sophie Belzacq's latest patents include groundbreaking inventions related to HIV viral protein R (Vpr) and its binding to the adenine nucleotide translocator (ANT). The inventions revolve around the induction of mitochondrial membrane permeabilization through the interaction of the HIV-1 Vpr protein with the mitochondrial inner membrane protein ANT. The patents offer reagents and methods aimed at inducing or inhibiting the binding of Vpr to ANT, exploring its implications for mitochondrial membrane permeabilization and apoptosis. These innovations stand to make significant impacts in the development of therapeutic strategies against HIV.
Career Highlights
Throughout her career, Anne-Sophie has worked with prestigious research institutions, including the Institut Pasteur and the Institut National de la Santé et de la Recherche Médicale. Her expertise in the field has positioned her as a key contributor to advancing our understanding of HIV's effects on cellular mechanisms.
Collaborations
Anne-Sophie Belzacq has collaborated with notable scientists such as Étienne Daniel François Jacotot and Guido Kroemer. These partnerships have enhanced her research efforts and broadened the impact of her work in the scientific community.
Conclusion
Anne-Sophie Belzacq exemplifies the spirit of innovation and dedication in the realm of biomedical research. Her patents reveal her commitment to tackling one of the most pressing health challenges of our time, providing new avenues for research and potential therapies for HIV. As she continues her work, her contributions will undoubtedly pave the way for future advancements in the field.